Plaintiffs Lack Standing In Flonase Suit: GSK
GlaxoSmithKline PLC says that plaintiffs who brought an indirect purchasers action alleging the company stalled the approval of a generic version of Flonase don't have standing because they failed to state...To view the full article, register now.
Already a subscriber? Click here to view full article